Department of Integrated Biomedical Science, College of Medicine, Cardiovascular and Metabolic Disease Center, Inje University, Busan 47392, Korea.
National Research Laboratory for Mitochondrial Signaling, Department of Physiology, College of Medicine, Cardiovascular and Metabolic Disease Center, Inje University, Busan 47392, Korea.
Front Biosci (Landmark Ed). 2017 Mar 1;22(7):1177-1194. doi: 10.2741/4541.
Mitochondria, are the powerhouses of cells, have their own DNA (mtDNA), regulate the transport of metabolites and ions, and impact cell physiology, survival, and death. Mitochondrial dysfunction, including impaired oxidative phosphorylation, preferentially affects heart function due to an imbalance of energy supply and demand. Recently, mitochondrial mutations and associated mitochondrial dysfunction were suggested as a causal factor of cardiac manifestations. Oxidative stress largely influences mtDNA stability due to oxidative modifications of mtDNA. Furthermore, the continuous replicative state of mtDNA and presence of minimal nucleoid structure render mitochondria vulnerable to oxidative damage and subsequent mutations, which impair mitochondrial functions. However, the occurrence of mtDNA heteroplasmy in the same mitochondrion or cell and presence of nuclear DNA-encoded mtDNA repair systems raise questions regarding whether oxidative stress-mediated mtDNA mutations are the major driving force in accumulation of mtDNA mutations. Here, we address the possible causes of mitochondrial DNA mutations and their involvement in cardiac manifestations. Current strategies for treatment related to mitochondrial mutations and/or dysfunction in cardiac manifestations are briefly discussed.
线粒体是细胞的“能量工厂”,拥有自己的 DNA(mtDNA),调节代谢物和离子的运输,并影响细胞的生理机能、存活和死亡。线粒体功能障碍,包括氧化磷酸化受损,由于能量供应和需求的失衡,优先影响心脏功能。最近,线粒体突变和相关的线粒体功能障碍被认为是心脏表现的一个因果因素。由于 mtDNA 的氧化修饰,氧化应激在很大程度上影响 mtDNA 的稳定性。此外,mtDNA 的连续复制状态和最小核区结构的存在使线粒体容易受到氧化损伤和随后的突变的影响,从而损害线粒体功能。然而,同一线粒体或细胞中 mtDNA 异质性的出现以及核 DNA 编码的 mtDNA 修复系统的存在,使得氧化应激介导的 mtDNA 突变是否是 mtDNA 突变积累的主要驱动力这一问题受到质疑。在这里,我们探讨了线粒体 DNA 突变的可能原因及其在心脏表现中的作用。简要讨论了与心脏表现相关的线粒体突变和/或功能障碍的治疗策略。